GANX
Gain Therapeutics Inc
1.80$
+4.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -18.6% | +1,354.6% | +305.9% | -38.2% | -22.8% | -34.9% | +88.2% | |
| – | -19.5% | +2,158.0% | +319.7% | -44.1% | -15.7% | -34.7% | +91.7% | |
| – | -24.3% | +2,370.3% | +392.2% | -80.2% | +61.3% | -11.9% | +100.6% | |
| – | -24.3% | +2,370.3% | +392.2% | -45.4% | -16.6% | -38.2% | +100.6% | |
| – | +7.5% | -81.0% | +2,186.5% | -46.9% | +133.5% | +215.7% | +4.8% | |
| – | – | +4,212.1% | – | – | – | – | – | |
| – | -28.3% | +152.0% | +82.2% | -85.7% | – | – | – | |
| – | – | – | – | +5.6% | -9.6% | -30.6% | -23.4% | |
| – | -37.0% | +206.5% | +22.5% | +25.3% | +15.5% | -20.7% | -11.1% | |
| – | +65.6% | +140.6% | +20.7% | +61.6% | +20.0% | -21.0% | -14.3% | |
| – | +4.6% | +42.4% | +122.1% | +4.4% | +3.3% | -22.2% | -18.6% | |
| – | +3.4% | +522.6% | -41.7% | +190.1% | -18.9% | -28.3% | -12.8% | |
| – | – | – | -17.5% | -16.1% | -9.3% | -26.9% | -8.6% | |
| – | – | – | +461.4% | -45.8% | -33.4% | -41.6% | +152.9% | |
| – | – | – | – | – | – | – | – | |
| – | +42.9% | +41.8% | -14.4% | +16.9% | +9.5% | +75.9% | +44.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.